MTFMT
Basic information
Region (hg38): 15:65001512-65029639
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation defect type 15 (Moderate), mode of inheritance: AR
- Leigh syndrome with leukodystrophy (Supportive), mode of inheritance: AR
- combined oxidative phosphorylation defect type 15 (Strong), mode of inheritance: AR
- Leigh syndrome (Definitive), mode of inheritance: AR
- combined oxidative phosphorylation defect type 15 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 15 | AR | Cardiovascular | Among other multi-systemic manifestations, the condition may include cardiac manifestations such as Wolff-Parkinson-White syndrome, and surveillance may allow early diagnosis and management | Biochemical; Cardiovascular; Neurologic; Ophthalmologic | 21907147; 22499348; 23499752; 24461907 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (184 variants)
- Inborn_genetic_diseases (70 variants)
- Combined_oxidative_phosphorylation_defect_type_15 (24 variants)
- not_specified (15 variants)
- MTFMT-related_disorder (11 variants)
- Mitochondrial_complex_I_deficiency,_nuclear_type_27 (6 variants)
- MTFMT-Related_Disorders (3 variants)
- Microcephaly (2 variants)
- Leigh_syndrome (2 variants)
- Decreased_activity_of_mitochondrial_complex_I (1 variants)
- Mitochondrial_oxidative_phosphorylation_disorder (1 variants)
- Cytochrome_C_oxidase-negative_muscle_fibers (1 variants)
- Inability_to_walk_by_childhood/adolescence (1 variants)
- See_cases (1 variants)
- Short_stature (1 variants)
- Poor_speech (1 variants)
- Abnormal_facial_shape (1 variants)
- Waardenburg_syndrome,_IIa_2F (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTFMT gene is commonly pathogenic or not. These statistics are base on transcript: NM_000139242.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 39 | 42 | ||||
missense | 103 | 12 | 127 | |||
nonsense | 11 | 14 | ||||
start loss | 1 | 1 | 1 | 3 | ||
frameshift | 10 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
Total | 22 | 13 | 105 | 51 | 7 |
Highest pathogenic variant AF is 0.000696738
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MTFMT | protein_coding | protein_coding | ENST00000220058 | 9 | 27133 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.50e-7 | 0.846 | 124614 | 0 | 47 | 124661 | 0.000189 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.462 | 214 | 196 | 1.09 | 0.00000987 | 2467 |
Missense in Polyphen | 70 | 69.718 | 1.004 | 810 | ||
Synonymous | -0.381 | 76 | 71.9 | 1.06 | 0.00000399 | 768 |
Loss of Function | 1.53 | 14 | 21.7 | 0.645 | 0.00000107 | 252 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000175 | 0.000175 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000112 | 0.000111 |
Finnish | 0.000186 | 0.000186 |
European (Non-Finnish) | 0.000313 | 0.000310 |
Middle Eastern | 0.000112 | 0.000111 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Formylates methionyl-tRNA in mitochondria. A single tRNA(Met) gene gives rise to both an initiator and an elongator species via an unknown mechanism (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Combined oxidative phosphorylation deficiency 15 (COXPD15) [MIM:614947]: An autosomal recessive, mitochondrial, neurologic disorder characterized by features of Leigh syndrome and combined oxidative phosphorylation deficiency. Clinical features include mild global developmental delay, white matter abnormalities, ataxia, incoordination, speech and reading difficulties, T2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem. {ECO:0000269|PubMed:21907147}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:22499348}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- One carbon pool by folate - Homo sapiens (human);Aminoacyl-tRNA biosynthesis - Homo sapiens (human);S-Adenosylhomocysteine (SAH) Hydrolase Deficiency;Methionine Metabolism;Folate malabsorption, hereditary;Methionine Adenosyltransferase Deficiency;Glycine N-methyltransferase Deficiency;Methylenetetrahydrofolate Reductase Deficiency (MTHFRD);Hypermethioninemia;Methylenetetrahydrofolate Reductase Deficiency (MTHFRD);Methotrexate Action Pathway;Folate Metabolism;Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type;Cystathionine Beta-Synthase Deficiency;One Carbon Metabolism;Mitochondrial translation initiation;Translation;Metabolism of proteins;Methionine and cysteine metabolism;Mitochondrial translation
(Consensus)
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- loftool
- 0.817
- rvis_EVS
- 0.71
- rvis_percentile_EVS
- 85.53
Haploinsufficiency Scores
- pHI
- 0.824
- hipred
- N
- hipred_score
- 0.229
- ghis
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.960
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mtfmt
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- translational initiation;conversion of methionyl-tRNA to N-formyl-methionyl-tRNA
- Cellular component
- mitochondrion
- Molecular function
- methionyl-tRNA formyltransferase activity